Iovance Biotherapeutics Inc. Common Stock vs Ovintiv Inc. (DE) — how do they compare? Iovance Biotherapeutics Inc. Common Stock trades at $14.78 (market cap $6.04B), while Ovintiv Inc. (DE) trades at $64.16 (market cap $17.53B). The key difference: Ovintiv Inc. (DE) is far larger — about 2.9× Iovance Biotherapeutics Inc. Common Stock's market cap, and Ovintiv Inc. (DE) pays a 1.89% dividend while Iovance Biotherapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Iovance Biotherapeutics Inc. Common Stock for 0 Days and Ovintiv Inc. (DE) for 1 Days on average.
| IOVA | OVV | |
|---|---|---|
Market Cap | $6.04B | $17.53B |
Volume | 14,805,993 | 3,002,714 |
Sector | Health | Energy |
52-Week High | $14.82 | $66.97 |
52-Week Low | $1.81 | $35.97 |
Typical Hold Time | 0 Days | 1 Days |
Enterprise Value | $5.97B | $21.86B |
Dividend Yield | — | 1.89% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Iovance Biotherapeutics develops cell therapies for cancer. Its approach uses tumor-infiltrating lymphocytes, or TIL, to target solid tumors.
Read more on IOVA →Ovintiv explores for and produces oil and natural gas in North America. Its operations are concentrated in major U.S. and Canadian resource basins.
Read more on OVV →